Abstract
Purpose
This study aimed to characterize a commercially available primary human nasal epithelial cell culture and its gene expression of a wide range of drug transporters under different culture conditions.
Methods
Human nasal cells were cultured in three different types of culture media at the air-liquid (A-L) or liquid-liquid (L-L) interfaces for 1 or 3 wks. The effects of the different cell culture conditions were evaluated using light and electron microscopy, transepithelial electrical resistance (TEER) measurements, permeation studies with dextran, and gene expression profiling of 84 drug transporters.
Results
The type of culture medium affected cell ultrastructure, TEER, and dextran permeation across epithelia. The expression of 20 drug transporter genes depended on the culture interface and/or time in culture; the A-L interface and longer time in culture favored higher expression levels of five ABC and seven SLC transporters.
Conclusions
Culture conditions influence the morphology, barrier formation, permeation properties, and drug transporter expression of human nasal epithelial cells, and this must be taken into consideration during the establishment and validation of in vitro models. A thorough characterization of a nasal epithelial model and its permeability properties is necessary to obtain an appropriate standardized model for the design of aerosol therapeutics and drug transport studies.
Similar content being viewed by others
Abbreviations
- ABC:
-
ATP-binding cassette
- AQP:
-
Aquaporin
- A-L:
-
Air-liquid interface
- DIV:
-
Days in vitro
- hAECN:
-
Human airway epithelial cells of nasal origin
- L-L:
-
Liquid-liquid interface
- SEM:
-
Scanning electron microscopy
- SLC:
-
Solute carrier
- TEER:
-
Transepithelial electrical resistance
- TEM:
-
Transmission electron microscopy
References
Audus KL, Bartel RL, Hidalgo IJ, Borchardt RT. The use of cultured epithelial and endothelial cells for drug transport and metabolism studies. Pharm Res. 1990;7(5):435–51.
Wengst A, Reichl S. RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studies. Eur J Pharms Biopharm: Off J Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV. 2010;74(2):290–7.
Kim D-D. In Vitro Cellular Models for Nasal Drug Absorption Studies. In: Ehrhardt C, Kim K-J, editors. Drug Absorption Studies. Biotechnology: Pharmaceutical Aspects. VII: Springer US; 2008. p. 216–34.
Karp PH, Moninger TO, Weber SP, Nesselhauf TS, Launspach JL, Zabner J, et al. An in vitro model of differentiated human airway epithelia. Methods for establishing primary cultures. Methods Mol Biol. 2002;188:115–37.
Werner U, Kissel T. In-vitro cell culture models of the nasal epithelium: a comparative histochemical investigation of their suitability for drug transport studies. Pharm Res. 1996;13(7):978–88.
Muller L, Brighton LE, Carson JL, Fischer WA, 2nd, Jaspers I. Culturing of human nasal epithelial cells at the air liquid interface. J Visual Exp: JoVE. 2013(80).
Fulcher ML, Randell SH. Human nasal and tracheo-bronchial respiratory epithelial cell culture. Methods Mol Biol. 2013;945:109–21.
Ong HX, Jackson CL, Cole JL, Lackie PM, Traini D, Young PM, et al. Primary air-liquid Interface culture of nasal epithelium for nasal drug delivery. Mol Pharm. 2016;13(7):2242–52.
Yoo JW, Kim YS, Lee SH, Lee MK, Roh HJ, Jhun BH, et al. Serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies. Pharm Res. 2003;20(10):1690–6.
Yoon JH, Moon HJ, Seong JK, Kim CH, Lee JJ, Choi JY, et al. Mucociliary differentiation according to time in human nasal epithelial cell culture. Differentiation; Res Biol Divers. 2002;70(2–3):77–83.
Werner U, Kissel T. Development of a human nasal epithelial cell culture model and its suitability for transport and metabolism studies under in vitro conditions. Pharm Res. 1995;12(4):565–71.
Chemuturi NV, Hayden P, Klausner M, Donovan MD. Comparison of human tracheal/bronchial epithelial cell culture and bovine nasal respiratory explants for nasal drug transport studies. J Pharm Sci. 2005;94(9):1976–85.
Koizumi J, Kojima T, Ogasawara N, Kamekura R, Kurose M, Go M, et al. Protein kinase C enhances tight junction barrier function of human nasal epithelial cells in primary culture by transcriptional regulation. Mol Pharmacol. 2008;74(2):432–42.
Shao D, Massoud E, Clarke D, Cowley E, Renton K, Agu RU. Optimization of human nasal epithelium primary culture conditions for optimal proton oligopeptide and organic cation transporters expression in vitro. Int J Pharm. 2013;441(1–2):334–42.
Fulcher ML, Gabriel S, Burns KA, Yankaskas JR, Randell SH. Well-differentiated human airway epithelial cell cultures. Methods Mol Med. 2005;107:183–206.
Lee MK, Yoo JW, Lin H, Kim YS, Kim DD, Choi YM, et al. Air-liquid interface culture of serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies. Drug Delivery. 2005;12(5):305–11.
Murgia C, Grosser D, Truong-Tran AQ, Roscioli E, Michalczyk A, Ackland ML, et al. Apical localization of zinc transporter ZnT4 in human airway epithelial cells and its loss in a murine model of allergic airway inflammation. Nutrients. 2011;3(11):910–28.
Widdicombe JH, Sachs LA, Morrow JL, Finkbeiner WE. Expansion of cultures of human tracheal epithelium with maintenance of differentiated structure and function. BioTechniques. 2005;39(2):249–55.
Kreft ME, Jerman UD, Lasič E, Lanišnik Rižner T, Hevir-Kene N, Peternel L, et al. The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model. Pharm Res. 2015;32(2):665–79.
Coecke S, Balls M, Bowe G, Davis J, Gstraunthaler G, Hartung T, et al. Guidance on good cell culture practice. A report of the second ECVAM task force on good cell culture practice. Altern Lab Anim. 2005;33(3):261–87.
Ferreira Lopes S, Vacher G, Ciarlo E, Savova-Bianchi D, Roger T, Niculita-Hirzel H. Primary and Immortalized Human Respiratory Cells Display Different Patterns of Cytotoxicity and Cytokine Release upon Exposure to Deoxynivalenol, Nivalenol and Fusarenon-X. Toxins (Basel). 2017;9(11).
Lötzerich M, Roulin PS, Boucke K, Witte R, Georgiev O, Greber UF. Rhinovirus 3C protease suppresses apoptosis and triggers caspase-independent cell death. Cell Death Dis. 2018;9(3):272.
Schmidt MC. Therapeutic peptides: how do they get through the nasal epithelium? Zurich: institute of technology Zurich (ETH); 1999.
Glorieux S, Bachert C, Favoreel HW, Vandekerckhove AP, Steukers L, Rekecki A, et al. Herpes simplex virus type 1 penetrates the basement membrane in human nasal respiratory mucosa. PLoS One. 2011;6(7):e22160.
Sibinovska N, Žakelj S, Kristan K. Suitability of RPMI 2650 cell models for nasal drug permeability prediction. Eur J Pharm Biopharm. 2019;145:85–95.
Dimova S, Brewster ME, Noppe M, Jorissen M, Augustijns P. The use of human nasal in vitro cell systems during drug discovery and development. Toxicol In vitro: Int J Publ Assoc BIBRA. 2005;19(1):107–22.
Kreft ME, Jerman UD, Lasič E, Hevir-Kene N, Rižner TL, Peternel L, et al. The characterization of the human cell line Calu-3 under different culture conditions and its use as an optimized in vitro model to investigate bronchial epithelial function. Eur J Pharm Sci. 2015;69:1–9.
Sibinovska N, Žakelj S, Roškar R, Kristan K. Suitability and functional characterization of two Calu-3 cell models for prediction of drug permeability across the airway epithelial barrier. Int J Pharm. 2020;585:119484.
Shao D, Massoud E, Anand U, Parikh A, Cowley E, Clarke D, et al. Organic cation transporters in human nasal primary culture: expression and functional activity. Ther Deliv. 2013;4(4):439–51.
Agu R, MacDonald C, Cowley E, Shao D, Renton K, Clarke DB, et al. Differential expression of organic cation transporters in normal and polyps human nasal epithelium: implications for in vitro drug delivery studies. Int J Pharm. 2011;406(1–2):49–54.
Agu R, Dang HV, Jorissen M, Willems T, Vandoninck S, Van Lint J, et al. In vitro polarized transport of L-phenylalanine in human nasal epithelium and partial characterization of the amino acid transporters involved. Pharm Res. 2003;20(8):1125–32.
Bleier BS, Nocera AL, Iqbal H, Hoang JD, Feldman RE, Han X. P-glycoprotein functions as an immunomodulator in healthy human primary nasal epithelial cells. Int Forum Allergy Rhinol. 2013;3(6):433–8.
Pezzulo AA, Starner TD, Scheetz TE, Traver GL, Tilley AE, Harvey BG, et al. The air-liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia. Am J Physiol Lung Cell Mol Physiol. 2011;300(1):L25–31.
Thompson K, Molina RM, Donaghey T, Schwob JE, Brain JD, Wessling-Resnick M. Olfactory uptake of manganese requires DMT1 and is enhanced by anemia. FASEB J: Off Publ Federation Am Soci Exp Biol. 2007;21(1):223–30.
Agu R, Cowley E, Shao D, Macdonald C, Kirkpatrick D, Renton K, et al. Proton-coupled oligopeptide transporter (POT) family expression in human nasal epithelium and their drug transport potential. Mol Pharm. 2011;8(3):664–72.
Chemuturi NV, Donovan MD. Role of organic cation transporters in dopamine uptake across olfactory and nasal respiratory tissues. Mol Pharm. 2007;4(6):936–42.
Genter MB, Krishan M, Augustine LM, Cherrington NJ. Drug transporter expression and localization in rat nasal respiratory and olfactory mucosa and olfactory bulb. Drug Metab Disposition: Biol Fate Chem. 2010;38(10):1644–7.
Kaler G, Truong DM, Sweeney DE, Logan DW, Nagle M, Wu W, et al. Olfactory mucosa-expressed organic anion transporter, Oat6, manifests high affinity interactions with odorant organic anions. Biochem Biophys Res Commun. 2006;351(4):872–6.
Genter MB, Kendig EL, Knutson MD. Uptake of materials from the nasal cavity into the blood and brain: are we finally beginning to understand these processes at the molecular level? Ann N Y Acad Sci. 2009;1170:623–8.
Kandimalla KK, Donovan MD. Localization and differential activity of P-glycoprotein in the bovine olfactory and nasal respiratory mucosae. Pharm Res. 2005;22(7):1121–8.
Kandimalla KK, Donovan MD. Carrier mediated transport of chlorpheniramine and chlorcyclizine across bovine olfactory mucosa: implications on nose-to-brain transport. J Pharm Sci. 2005;94(3):613–24.
Al-Ghabeish M, Scheetz T, Assem M, Donovan MD. Microarray determination of the expression of drug transporters in humans and animal species used for the investigation of nasal absorption. Mol Pharm. 2015;12(8):2742–54.
Dolberg AM, Reichl S. Expression of P-glycoprotein in excised human nasal mucosa and optimized models of RPMI 2650 cells. Int J Pharm. 2016;508(1–2):22–33.
Mercier C, Jacqueroux E, He Z, Hodin S, Constant S, Perek N, et al. Pharmacological characterization of the 3D MucilAir™ nasal model. Eur J Pharm Biopharm. 2019;139:186–96.
Pozzoli M, Ong HX, Morgan L, Sukkar M, Traini D, Young PM, et al. Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products. Eur J Pharm Biopharm: Off J Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV. 2016;107:223–33.
Fotiadis D, Kanai Y, Palacin M. The SLC3 and SLC7 families of amino acid transporters. Mol Asp Med. 2013;34(2–3):139–58.
Seno S, Ogawa T, Shibayama M, Kouzaki H, Shimizu T. Expression and localization of aquaporin 1, 2, 3, 4, and 5 in human nasal mucosa. Am J Rhinol Allergy. 2012;26(3):167–71.
Ablimit A, Matsuzaki T, Tajika Y, Aoki T, Hagiwara H, Takata K. Immunolocalization of water channel aquaporins in the nasal olfactory mucosa. Arch Histol Cytol. 2006;69(1):1–12.
Yuan L, Lv B, Zha J, Wang W, Wang Z. Basal and benzo[a]pyrene-induced expression profile of phase I and II enzymes and ABC transporter mRNA in the early life stage of Chinese rare minnows (Gobiocypris rarus). Ecotoxicol Environ Saf. 2014;106:86–94.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Supplemental Table 1
(DOCX 33 kb)
Supplemental Table 2
(DOCX 20 kb)
Supplemental Fig. 1
The main ultrastructural characteristics of hAECN. These characteristics were observed irrespective of the media used. Rough endoplasmic reticulum (ER) is scarce in the cytoplasm, the Golgi apparatus (GA) is simple, normal mitochondria (M) and endocytotic compartments (E) are present, and bundles of cytoskeletal filaments (arrows) are abundant. Scale bar: 500 nm. (PNG 1048 kb)
Supplemental Fig. 2
Immunofluorescence labelling of tight junctional protein occludin (A–C), adherent junction protein E-cadherin (D–F), and cytokeratin 7 (CK7, G–I) in hAECN of passage P3 maintained in Epithelix, PromoCell, and A-MEM for 1 wk. Nuclei are blue. Scale bar: 10 μm. (PNG 4399 kb)
Supplemental Fig. 3
Transepithelial permeation of dextran-FITC across hAECN, RPMI2560, and Calu-3 epithelial models at 30 min (left) and 3 h (right) (n = 3–4, mean ± SE). The cells were maintained in A-MEM at the A-L or L-L interface. (PNG 170 kb)
Rights and permissions
About this article
Cite this article
Kreft, M.E., Tratnjek, L., Lasič, E. et al. Different Culture Conditions Affect Drug Transporter Gene Expression, Ultrastructure, and Permeability of Primary Human Nasal Epithelial Cells. Pharm Res 37, 170 (2020). https://doi.org/10.1007/s11095-020-02905-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11095-020-02905-w